2015 Research Report

Dr. Howard Lincoln Snyder (H. L.) was a well-respected and beloved physician in Winfield from 1904 and until his death on August 16, 1940.  Dr. H. L. had the foresight to understand that medicine was on the verge of experiencing great advances and growth.  He believed that this could occur only through medical research, delving into the complexities of diseases.  It was this conviction that prompted Mr. And Mrs. William Moorer to generously contribute the first $5,500, which was used by Dr. Cecil Snyder and others in the Winfield community to establish a fund to form the H. L. Snyder Medical Foundation (HLSMF).  This fund has grown to over $10 million today.

HLSMF is a nonprofit organization funded by private and public donations, dedicated to biomedical research and the dissemination of information.  Located at 1407 Wheat Road in Winfield, Kansas, the Foundation’s goals are to provide support for exceptional research at world-class research institutions, to provide scholarships for local students going into the medical field and to support charitable and public organizations in the Winfield area for the advancement of: medicine, surgery and healthcare.  Our research efforts are currently directed at providing an extra boost for research nearing a significant discovery as well as providing support for very basic research studying mechanisms involved in pathophysiologic processes of human disease.  

Since closing our laboratory in 2004, we have supported research at several different institutions.  The three we are currently supporting are detailed in the next pages.  Our support does not include salary for principle investigators, but rather is used to buy equipment, supplies or technical support.

There have been very exciting developments in the labs of all the scientists we are currently supporting during the past year.  The goal of the H. L. Snyder Medical Foundation's research has been, since its inception, to discover and to provide procedures or medications that would be of immediate benefit to patients.  One of the earliest was to develop a solution to dissolve a kidney stone in a patient in the 1940's by the then director of the lab, Leitha Bunch.  Although much of the information is still confidential, there are exciting discoveries in four of the labs that will almost certainly lead to treatments or procedures that will directly benefit patients numbering in the millions.  This is exciting news for all of our trustees, our members on the Research Committee, as well as to the general public.